Researchers can invent and test millions of molecules quickly, but to develop successful new drugs, agrochemicals and other futuristic materials, they must first synthesize the molecules—and outcomes are a gamble. To solve this problem, Timothy Cernak’s laboratory at the University of Michigan College of Pharmacy was awarded $3 million by Schmidt Futures recently to develop molecular reaction data using high-throughput experimentation, and the software to process it. The data will be available to all and the software will be free to academia. Read the full article here.
Recent Posts
- Live cell screening to identify RNA-binding small molecule inhibitors of the pre-let-7–Lin28 RNA– protein interaction
- Structure–Activity Relationships of Natural and Semisynthetic Plecomacrolides Suggest Distinct Pathways for HIV-1 Immune Evasion and Vacuolar ATPase-Dependent Lysosomal Acidification
- AI is a Viable Alternative to High Throughput Screening
- New Assay for Discovery of Novel RNA Targeting Antibacterials
- Accelerating Drug Discovery in Michigan